Glenmark Pharmaceuticals introduce EMI scheme for cancer treatment drugs

Glenmark Pharmaceuticals introduce EMI scheme for cancer treatment drugs

Glenmark Pharmaceuticals has rolled out an EMI scheme for cancer patients in order to help them continue the treatment and meet the high cost of medication. The Mumbai-based company has included its two drugs — Abirapro prescribed for prostate cancer …

(Visited 1 times, 1 visits today)
1
Like
Save

Comments

Comments are disabled for this post.